But It Sounds Like Something's Changing | GenomeWeb

DrugMonkey doesn't think much of the new NIH rules to address financial conflict of interest among researchers. In fact, he says, the tighter rules "will do absolutely nothing about real COI." For one thing, DrugMonkey says, lowering the reporting threshold from $10,000 to $5,000 won't do anything about the PIs who caused scandal and were investigated by Congress for making hundreds of thousands of dollars from big pharma without reporting it.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.